Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.

Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.

Item
http://www.wikidata.org/entity/Q38799284
New milestones ahead in complement-targeted therapy.Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.IVIg attenuates complement and improves spinal cord injury outcomes in mice.The renaissance of complement therapeutics.Novel mechanisms and functions of complement.Complement C5a Receptor 1 Exacerbates the Pathophysiology of N. meningitidis Sepsis and Is a Potential Target for Disease Treatment.Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.Complement components are upregulated and correlate with disease progression in the TDP-43Q331K mouse model of amyotrophic lateral sclerosis.Development and validation of a LC-MS/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice.
P2860

Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.

Item
http://www.wikidata.org/entity/Q38799284
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Therapeutic targeting of compl ...... es in neurological conditions.
@en
type
label
Therapeutic targeting of compl ...... es in neurological conditions.
@en
prefLabel
Therapeutic targeting of compl ...... es in neurological conditions.
@en
P1433
P1476
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Therapeutic targeting of compl ...... es in neurological conditions.
@en
P304
P31
P356
10.1016/J.SMIM.2016.03.015
P433
P478
P50
P577
P698